Sulan Luo

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Topics

Neuropathic Pain

Anti Inflammatory

Carbon Nanotubes

Top Venues

Journal of medicinal chemistry

Bioconjugate chemistry

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Pan Xu, Panpan Zhang, Xiaopeng Zhu, Yong Wu, Peta J Harvey, Quentin Kaas, Dongting Zhangsun, David J Craik, Sulan Luo
Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA[1,2] and GeXIVA[1,4]. Journal of medicinal chemistry (2023)
Xiaopeng Zhu, Shuai Wang, Quentin Kaas, Jinpeng Yu, Yong Wu, Peta J Harvey, Dongting Zhangsun, David J Craik, Sulan Luo
Discovery, Characterization, and Engineering of LvIC, an α4/4-Conotoxin That Selectively Blocks Rat α6/α3β4 Nicotinic Acetylcholine Receptors. Journal of medicinal chemistry 66 (3) (2023)
Xiaopeng Zhu, Shuai Wang, Quentin Kaas, Jinpeng Yu, Yong Wu, Peta J Harvey, Dongting Zhangsun, David J Craik, Sulan Luo
Discovery, Characterization, and Engineering of LvIC, an α4/4-Conotoxin That Selectively Blocks Rat α6/α3β4 Nicotinic Acetylcholine Receptors. Journal of medicinal chemistry 66 (3) (2023)
Xiaopeng Zhu, Shuai Wang, Quentin Kaas, Jinpeng Yu, Yong Wu, Peta J Harvey, Dongting Zhangsun, David J Craik, Sulan Luo
Discovery, Characterization, and Engineering of LvIC, an α4/4-Conotoxin That Selectively Blocks Rat α6/α3β4 Nicotinic Acetylcholine Receptors. Journal of medicinal chemistry 66 (3) (2023)
Shengrong Pei, Chenxing Xu, Yao Tan, Meiting Wang, Jinpeng Yu, Dongting Zhangsun, Xiaopeng Zhu, Sulan Luo
Synthesis, Activity, and Application of Fluorescent Analogs of [D1G, Δ14Q]LvIC Targeting α6β4 Nicotinic Acetylcholine Receptor. Bioconjugate chemistry (2023)
Xiaopeng Zhu, Shuai Wang, Quentin Kaas, Jinpeng Yu, Yong Wu, Peta J Harvey, Dongting Zhangsun, David J Craik, Sulan Luo
Discovery, Characterization, and Engineering of LvIC, an α4/4-Conotoxin That Selectively Blocks Rat α6/α3β4 Nicotinic Acetylcholine Receptors. Journal of medicinal chemistry (2023)
Shuai Wang, Xiaopeng Zhu, Manqi Zhangsun, Yong Wu, Jinpeng Yu, Peta J Harvey, Quentin Kaas, Dongting Zhangsun, David J Craik, Sulan Luo
Engineered Conotoxin Differentially Blocks and Discriminates Rat and Human α7 Nicotinic Acetylcholine Receptors. Journal of medicinal chemistry 64 (9) (2021)
Yishuai Yang, Yao Tan, Dongting Zhangsun, Xiaopeng Zhu, Sulan Luo
Design, Synthesis, and Activity of an α-Conotoxin LtIA Fluorescent Analogue. ACS chemical neuroscience 12 (19) (2021)
Pan Xu, Quentin Kaas, Yong Wu, Xiaopeng Zhu, Xincan Li, Peta J Harvey, Dongting Zhangsun, David J Craik, Sulan Luo
Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA. Journal of medicinal chemistry 63 (4) (2020)
Xiaopeng Zhu, Si Pan, Manyu Xu, Lu Zhang, Jinfang Yu, Jinpeng Yu, Yong Wu, Yingxu Fan, Haonan Li, Igor E Kasheverov, Denis S Kudryavtsev, Victor I Tsetlin, Yi Xue, Dongting Zhangsun, Xinquan Wang, Sulan Luo
High Selectivity of an α-Conotoxin LvIA Analogue for α3β2 Nicotinic Acetylcholine Receptors Is Mediated by β2 Functionally Important Residues. Journal of medicinal chemistry 63 (22) (2020)
Jinpeng Yu, Xiaopeng Zhu, Peta J Harvey, Quentin Kaas, Dongting Zhangsun, David J Craik, Sulan Luo
Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist. Journal of medicinal chemistry 61 (20) (2018)
Yong Wu, Dongting Zhangsun, Xiaopeng Zhu, Quentin Kaas, Manqi Zhangsun, Peta J Harvey, David J Craik, J Michael McIntosh, Sulan Luo
α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors. Journal of medicinal chemistry 60 (13) (2017)